Roivant Sciences Stock Book Value Per Share
Roivant Sciences fundamentals help investors to digest information that contributes to Roivant Sciences' financial success or failures. It also enables traders to predict the movement of Roivant Stock. The fundamental analysis module provides a way to measure Roivant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roivant Sciences stock.
Roivant |
Roivant Sciences Company Book Value Per Share Analysis
Roivant Sciences' Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Roivant Sciences Book Value Per Share | 7.74 X |
Most of Roivant Sciences' fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roivant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Roivant Sciences is about 7.738 times. This is 555.18% lower than that of the Biotechnology sector and 103.11% lower than that of the Health Care industry. The book value per share for all United States stocks is 99.6% higher than that of the company.
Roivant Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roivant Sciences' direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Roivant Sciences could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics of similar companies.Roivant Sciences is currently under evaluation in book value per share category among its peers.
Roivant Fundamentals
| Operating Margin | (37.08) % | |||
| Number Of Shares Shorted | 215.84 K | |||
| Revenue | 61.28 M | |||
| EBITDA | (1.11 B) | |||
| Net Income | (1.12 B) | |||
| Cash And Equivalents | 2 B | |||
| Cash Per Share | 8.97 X | |||
| Total Debt | 481.4 M | |||
| Debt To Equity | 0.13 % | |||
| Current Ratio | 9.84 X | |||
| Book Value Per Share | 7.74 X | |||
| Cash Flow From Operations | (843.39 M) | |||
| Earnings Per Share | (4.09) X | |||
| Number Of Employees | 620 | |||
| Total Asset | 2.39 B | |||
| Retained Earnings | (3.77 B) | |||
| Working Capital | 1.53 B | |||
| Z Score | -2.95 | |||
| Net Asset | 2.39 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in Roivant Stock
If you are still planning to invest in Roivant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Roivant Sciences' history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |